Plain-English translation of NCT07621549 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new treatment called transcranial ultrasound stimulation—a non-invasive procedure that uses gentle, focused ultrasound waves to stimulate specific areas of the brain. The study aims to see whether this approach is safe and whether it might help reduce symptoms of schizophrenia, including difficulties with thinking, mood, and daily functioning.
Current treatments for schizophrenia help many people, but not everyone responds well, and some patients experience side effects. This treatment is being explored as a potentially new option that might work differently and offer another path to symptom relief.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive sessions of ultrasound brain stimulation targeting the hippocampus and nearby brain regions. Before and after treatment, you will have heart monitoring, blood tests, and assessments of your psychiatric symptoms, mood, and thinking abilities. The study will evaluate whether the treatment is safe and whether it helps improve your symptoms.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Taiwan
Sponsor
Far Eastern Memorial Hospital
Enrollment target
~80 participants
Started
June 2025
Primary completion
December 2028
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yi-Ju Pan
Far Eastern Memorial Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.